![Ionis Pharmaceuticals, Inc. logo](/logos/IONS.webp)
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
Overview | Financials
Company Name | Ionis Pharmaceuticals, Inc. |
Symbol | IONS |
Currency | USD |
Price | 46.89 |
Market Cap | 6,855,833,790 |
Dividend Yield | 0% |
52-week-range | 35.95 - 54.44 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Brett P. Monia Ph.D. |
Website | https://www.ionispharma.com |
An error occurred while fetching data.
About Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD